VERTEX PHARMACEUTICALS INC / MA (VRTX)
Pharmaceutical Preparations · Pharmaceutical Preparations · NASDAQ
$528.19
+2.45%
Investingg Score
67.7 / 100
Hold
Business overview
- Operating margin stands at 34.8%
- FCF margin is reported at 26.6%
- Gross margin is noted as Data unavailable.
These high operating and free cash flow margins indicate strong core profitability and efficient cash generation within the pharmaceutical preparations industry.
Financial health
- Balance Sheet pillar score is registered at 59
- Overall company score is 67.7 with a Hold verdict
- Additional balance sheet specifics such as debt-to-equity are Data unavailable.
This moderate balance sheet score suggests a stable financial position, though comprehensive debt and liquidity metrics remain unquantified.
- Gross Margin
- Data unavailable
- Operating Margin
- 34.8%
- Current Ratio
- 2.9x
- Debt / Equity
- Data unavailable
- Free Cash Flow (TTM)
- $3.2B
- Interest Coverage
- Data unavailable
Valuation
- Price-to-earnings ratio is 31.59
- Price-to-sales ratio is 10.85
- Free cash flow yield is 2.4%
- Valuation pillar score is 53
These elevated multiples suggest that the market is pricing in substantial future performance expectations, creating a neutral valuation stance.
- P/E (TTM)
- 31.6x
- Forward P/E
- Data unavailable
- Price / Sales
- 10.8x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 2.4%
Key risks
- The valuation relies on high multiples, with a P/E ratio of 31.59 and a low free cash flow yield of 2.4%, introducing multiple contraction risk.
- The RSI of 68.77 approaches overbought territory, pointing to potential near-term consolidation uncertainty.
- Key detailed financial health and specific debt metrics are Data unavailable, creating visibility gaps.
Market cap $134.2B · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze VRTX with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.